Article thumbnail

Tumour-specific HMG-CoAR is an independent predictor of recurrence free survival in epithelial ovarian cancer

By Donal J Brennan, Jenny Brändstedt, Elton Rexhepaj, Michael Foley, Fredrik Pontén, Mathias Uhlén, William M Gallagher, Darran P O'Connor, Colm O'Herlihy and Karin Jirstrom
Topics: Research Article
Publisher: BioMed Central
OAI identifier: oai:pubmedcentral.nih.gov:3087316
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles

Citations

  1. (2004). Elson CE: Studies of the isoprenoid-mediated inhibition of mevalonate synthesis applied to cancer chemotherapy and chemoprevention. Exp Biol Med
  2. (2002). Isoprenoids as mediators of the biological effects of statins.
  3. (1992). O: Requirement for mevalonate in the control of proliferation of human breast cancer cells. Anticancer Res